Skip to main content
Caplight Logo









Generate Biomedicines

Generate Biomedicines

Public
Somerville, MassachusettsBiotechhttps://generatebiomedicines.com/

Generate Biomedicines is now publicly traded

The data on this page reflects Generate Biomedicines's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Feb 27, 2026

Last Round

Corporate Funding

Dec 18, 2024

Total Funding Raised

$1.11B

Company Overview

Generate Biomedicines is a biotechnology company that utilizes a generative biology platform to create innovative drugs across various protein modalities and therapeutics.

Sector

Biotech

Verticals

Artificial Intelligence & Machine Learning, HealthTech, Life Sciences

AI Layer

Application

Keywords

generative biologyprotein therapeuticsdrug discoveryai drug discoveryprotein designin silico drug designbiotech platformcomputational biologycancer immunotherapytherapeutic pipelinemachine learning biologybiotech stockpharma partnership

Generate Biomedicines Comparables

Compare Generate Biomedicines with similar companies based on industry and business-model similarity.

Generate Biomedicines comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
AbSci
87%
Chai Discovery
84%
Insilico Medicine
83%

Generate Biomedicines Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
IPOFeb 27, 2026
Corporate FundingDec 18, 2024
Corporate FundingSep 24, 2024
Series CSep 14, 2023
Series BNov 18, 2021
Series A
Sep 10, 2020

Key People

Founding team and executive leadership

Michael Nally

CEO At Generate Biomedicines

Executive Team

Gevorg Grigoryan

Founding CTO

Founding Team

Jason Silvers

Chief Financial Officer

Executive Team

Generate Biomedicines Investors

Notable investors and investment history

Generate Biomedicines investors
InvestorRounds
Human CapitalSeries B
Pictet GroupSeries C
Mirae AssetSeries C
Guggenheim SecuritiesIPO
Altitude Life Science VenturesSeries B, Series C
MAPS Capital ManagementSeries C
ARCH Venture PartnersSeries B, Series C

Recent news

Latest coverage and updates

  • attends_eventAug 27, 2026

    Generate Biomedicines attended event ERS Congress 2026 on Jul 1st '26.

  • has_revenueAug 27, 2026

    Generate Biomedicines had revenue of $6.31M on Aug 27th '26.

Generate Biomedicines Filings

Explore SEC and related filing metadata, where available.

Generate Biomedicines filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Firmographic Details

HeadquartersSomerville, Massachusetts
Employee Range292
Year Founded2018
Last FundingDec 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?